<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02383056</url>
  </required_header>
  <id_info>
    <org_study_id>20120475</org_study_id>
    <nct_id>NCT02383056</nct_id>
  </id_info>
  <brief_title>Doubleblinded RCT of the Omnilux on Lower Extremity Surgical Wounds Left to Heal by Second Intention</brief_title>
  <official_title>Doubleblinded, Randomized, Controlled Trial to Study the Effect of Omnilux Light Emitting Diode on Wound Healing Following Lower Extremity Surgical Wounds Left to Heal by Second Intention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the study is to evaluate the effectiveness of the light-emitting diode (LED) in
      promoting healing of the wound on lower leg as a result of surgery. Wounds on the lower leg
      heal more slowly than wounds on the head and neck; they can also remain deep red for six
      months to one year. Doctors usually allow a lower leg surgical wound to heal by itself,
      without stitches or other additional treatment. This is because leg wounds do not hold
      stitches well and stitches could cause other problems. A major drawback of allowing a
      surgical wound on the lower leg to heal by itself is the long healing time that can often
      take months. The investigators wish to evaluate if the LED light treatment of the surgical
      wound will improve the healing of your wound.

      In order to test if leg wounds heal faster after treatment with LED, half of the patients in
      the study will receive the LED (Group 2) and half will not receive treatment with LED but
      will receive a &quot;sham light&quot; treatment (Group 1). Essentially, a sham light treatment refers
      to regular light (not LED) exposure for 20 minutes. The sham light comes from the same device
      as the treatment light (Omnilux machine) however, this light has no anticipated effects on
      wound healing and is used simply to reduce the amount of bias that sometimes complicates the
      results of these studies. There is no added risk or benefit for the patients in the control
      group exposed to the sham light. Both groups will receive the standard care of wounds on the
      lower extremity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Group 2 of this study will receive the LED and half will not receive treatment with LED but
      will receive a &quot;sham light&quot; treatment (Group 1). Essentially, a sham light treatment refers
      to regular light (not LED) exposure for 20 minutes. The sham light comes from the same device
      as the treatment light (Omnilux machine) however, this light has no anticipated effects on
      wound healing and is used simply to reduce the amount of bias that sometimes complicates the
      results of these studies. There is no added risk or benefit for the patients in the control
      group exposed to the sham light. Both groups will receive the standard care of wounds on the
      lower extremity.

      Groups 1 and 2 will receive 4 sham light or treatment sessions, respectively (one session
      every week for 4 weeks). After these sessions are done, all subjects will continue weekly
      follow up visits until the wound is closed, or 3 months after the surgery have passed; which
      ever happens first.

      One final follow up visit will occur 1 week after the wound closed.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Sufficient enrollment achieved for outcome measures
  </why_stopped>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Days Required for the Wound to Heal Completely</measure>
    <time_frame>84 days</time_frame>
    <description>Assessment by the physician indicating wound closure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Relative Area of the Surgical Wound Remaining</measure>
    <time_frame>Week 1 to Week 2, Week 2 to Week 3, Week 3 to Week 4</time_frame>
    <description>Initial area * ((total area in the evaluated week/total area in the first week) * 100) and reported as a percentage (%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Total Surface Area of the Surgical Wound</measure>
    <time_frame>Week 1 to Week 2, Week 2 to Week 3, Week 3 to Week 4, Week 1 to Week 4</time_frame>
    <description>A blinded investigator manually outlines the wound using a digital planimetry device to measure the surface area in square centimeters.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Wound</condition>
  <arm_group>
    <arm_group_label>Sham Group (Group 1)</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>This group will receive 4 sessions of Omnilux sham light, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment group (Group 2)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive 4 treatment sessions with Omnilux 633nm LED, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Omnilux</intervention_name>
    <description>Photomodulation irradiated with a 633 +/- 3 mm light source for 20 minutes (105 mW/cm, 126 J/cm)</description>
    <arm_group_label>Treatment group (Group 2)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Omnilux Sham</intervention_name>
    <description>Sham light instead of phototherapy from the same light device</description>
    <arm_group_label>Sham Group (Group 1)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Surgical defect on the lower extremity left to heal by secondary intention.

          -  If women of child bearing potential, contraceptive measures should be used

          -  Maximum size of wound is 5cm x5cm; there is no minimum size for the wound.

        Exclusion Criteria:

          -  History of porphyria photosensitive eruptions, diabetes mellitus, history of venous
             insufficiency, known history of peripheral arterial disease (ABI &lt;0.8)

          -  Use of any ointments or creams containing photosensitizers (coumarins or porphyrins)
             should be discontinued for 2 weeks prior

          -  Use of systemic or local retinoids for the past 6 months.

          -  Current pregnancy or breastfeeding

          -  History of metastatic cancer.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keyvan Nouri, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Miami Hospital and Clinics/Sylvester Comprehensive Cancer Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>February 27, 2015</study_first_submitted>
  <study_first_submitted_qc>March 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2015</study_first_posted>
  <results_first_submitted>April 3, 2019</results_first_submitted>
  <results_first_submitted_qc>May 2, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 23, 2019</results_first_posted>
  <last_update_submitted>May 2, 2019</last_update_submitted>
  <last_update_submitted_qc>May 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Keyvan Nouri</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>wound</keyword>
  <keyword>secondary intention healing</keyword>
  <keyword>lower extremity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 10, 2012</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/56/NCT02383056/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Sham Group (Group 1)</title>
          <description>This group will receive 4 sessions of Omnilux sham light, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes
Omnilux sham light</description>
        </group>
        <group group_id="P2">
          <title>Treatment Group (Group 2)</title>
          <description>This group will receive 4 treatment sessions with Omnilux 633nm LED, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes
Omnilux: 633nm</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sham Group (Group 1)</title>
          <description>This group will receive 4 sessions of Omnilux sham light, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes
Omnilux sham light</description>
        </group>
        <group group_id="B2">
          <title>Treatment Group (Group 2)</title>
          <description>This group will receive 4 treatment sessions with Omnilux 633nm LED, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes
Omnilux: 633nm</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7"/>
            <count group_id="B2" value="7"/>
            <count group_id="B3" value="14"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.3" spread="7.39"/>
                    <measurement group_id="B2" value="72.6" spread="5.41"/>
                    <measurement group_id="B3" value="71.0" spread="6.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="7"/>
                    <count group_id="B3" value="14"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Days Required for the Wound to Heal Completely</title>
        <description>Assessment by the physician indicating wound closure</description>
        <time_frame>84 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham Group (Group 1)</title>
            <description>This group will receive 4 sessions of Omnilux sham light, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes
Omnilux sham light</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group (Group 2)</title>
            <description>This group will receive 4 treatment sessions with Omnilux 633nm LED, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes
Omnilux: 633nm</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Days Required for the Wound to Heal Completely</title>
          <description>Assessment by the physician indicating wound closure</description>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.67" spread="11.10"/>
                    <measurement group_id="O2" value="63.20" spread="12.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Relative Area of the Surgical Wound Remaining</title>
        <description>Initial area * ((total area in the evaluated week/total area in the first week) * 100) and reported as a percentage (%)</description>
        <time_frame>Week 1 to Week 2, Week 2 to Week 3, Week 3 to Week 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham Group (Group 1)</title>
            <description>This group will receive 4 sessions of Omnilux sham light, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes
Omnilux sham light</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group (Group 2)</title>
            <description>This group will receive 4 treatment sessions with Omnilux 633nm LED, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes
Omnilux: 633nm</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Relative Area of the Surgical Wound Remaining</title>
          <description>Initial area * ((total area in the evaluated week/total area in the first week) * 100) and reported as a percentage (%)</description>
          <units>Percentage of Wound Remaining</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 1 to Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.80" spread="19.40"/>
                    <measurement group_id="O2" value="96.0" spread="23.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 to Week 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.70" spread="8.71"/>
                    <measurement group_id="O2" value="77.40" spread="5.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3 to Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.10" spread="17.0"/>
                    <measurement group_id="O2" value="45.98" spread="20.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Total Surface Area of the Surgical Wound</title>
        <description>A blinded investigator manually outlines the wound using a digital planimetry device to measure the surface area in square centimeters.</description>
        <time_frame>Week 1 to Week 2, Week 2 to Week 3, Week 3 to Week 4, Week 1 to Week 4</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Sham Group (Group 1)</title>
            <description>This group will receive 4 sessions of Omnilux sham light, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes
Omnilux sham light</description>
          </group>
          <group group_id="O2">
            <title>Treatment Group (Group 2)</title>
            <description>This group will receive 4 treatment sessions with Omnilux 633nm LED, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes
Omnilux: 633nm</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Total Surface Area of the Surgical Wound</title>
          <description>A blinded investigator manually outlines the wound using a digital planimetry device to measure the surface area in square centimeters.</description>
          <units>Cm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Week 1 to Week 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.18" spread="0.57"/>
                    <measurement group_id="O2" value="-0.25" spread="0.62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2 to Week 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.93" spread="0.82"/>
                    <measurement group_id="O2" value="-0.48" spread="0.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3 to Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.27" spread="0.60"/>
                    <measurement group_id="O2" value="-0.80" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1 to Week 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.38" spread="1.03"/>
                    <measurement group_id="O2" value="-1.53" spread="0.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>4 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Sham Group (Group 1)</title>
          <description>This group will receive 4 sessions of Omnilux sham light, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes
Omnilux sham light</description>
        </group>
        <group group_id="E2">
          <title>Treatment Group (Group 2)</title>
          <description>This group will receive 4 treatment sessions with Omnilux 633nm LED, starting 1 week after the surgery. Frequency: 1 session every week (+/- 3 days), for 4 weeks. Session duration: 20 minutes
Omnilux: 633nm</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MeDRA (22.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="7"/>
              </event>
              <event>
                <sub_title>Pruritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7"/>
              </event>
              <event>
                <sub_title>Tenderness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="7"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Keyvan Nouri</name_or_title>
      <organization>University of Miami</organization>
      <phone>305-243-3380</phone>
      <email>Knouri@med.miami.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

